A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)

Status:
Not yet recruiting

Trial end date:
2020-10-16

Target enrollment:

Participant gender:

The purpose of this study is to assess levels in blood plasma of BMS-986278 and the food effect in healthy participants.

Phase 1

Bristol-Myers Squibb

Esomeprazole